Lista de obras - Eva Maria Galan-Moya - Dominio Público Uruguay

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

artículo científico publicado en 2019

Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC

artículo científico publicado en 2011

Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer

artículo científico publicado en 2020

Cost Effective Use of a Thiosulfinate-Enriched Allium sativum Extract in Combination with Chemotherapy in Colon Cancer

scientific article published on 16 April 2020

Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor.

artículo científico publicado en 2012

Endothelial secreted factors suppress mitogen deprivation-induced autophagy and apoptosis in glioblastoma stem-like cells

artículo científico publicado en 2014

Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene

artículo científico publicado en 2018

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

artículo científico publicado en 2019

Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma.

artículo científico publicado en 2015

Functional transcriptomic annotation and protein-protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer.

artículo científico publicado en 2018

Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer.

artículo científico publicado en 2018

Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors

article

Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2

artículo científico publicado en 2012

Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer

scientific article published on 12 March 2020

Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs

artículo científico publicado en 2017

Mapping Bromodomains in breast cancer and association with clinical outcome

scientific article published on 05 April 2019

Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C.

artículo científico publicado en 2005

PAKing up to the endothelium.

artículo científico publicado en 2009

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer

artículo científico publicado en 2020

RETRACTED ARTICLE: P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance ⬇️

artículo científico publicado el 15 de agosto de 2011

Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor.

artículo científico publicado en 2010

Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway.

artículo científico publicado en 2011

Synthetic lethality interaction between Aurora kinases and CHEK1 inhibitors in ovarian cancer.

artículo científico

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors

artículo científico publicado en 2017

The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity.

artículo científico publicado en 2015

Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors

artículo científico publicado en 2017

Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer

artículo científico publicado en 2019

c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy.

artículo científico publicado en 2008

Lista de obras de Eva Maria Galan-Moya

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC

Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer

Cost Effective Use of a Thiosulfinate-Enriched Allium sativum Extract in Combination with Chemotherapy in Colon Cancer

Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor.

Endothelial secreted factors suppress mitogen deprivation-induced autophagy and apoptosis in glioblastoma stem-like cells

Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma.

Functional transcriptomic annotation and protein-protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer.

Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer.

Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors

Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2

Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer

Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs

Mapping Bromodomains in breast cancer and association with clinical outcome

Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C.

PAKing up to the endothelium.

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer

RETRACTED ARTICLE: P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance ⬇️

Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor.

Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway.

Synthetic lethality interaction between Aurora kinases and CHEK1 inhibitors in ovarian cancer.

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors

The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity.

Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors

Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer

c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy.